Should You Buy WUXI BIO (02269) Today? Analysis, Price Targets, and 2026 Outlook.
No data
No data
Growth
Profitability
Efficiency
Wall Street analysts forecast 02269 stock price to rise
0 Analyst Rating
0
Wall Street analysts forecast 02269 stock price to rise
0 Buy
0 Hold
0 Sell
0
Current: 36.780
Low
0
Averages
0
High
0
0
Current: 36.780
Low
0
Averages
0
High
0
UBS
NULL -> Buy
upgrade
AI Analysis
2026-07-03
Reason
UBS
Price Target
AI Analysis
2026-07-03
upgrade
NULL -> Buy
Reason
UBS raised its revenue forecasts for WUXI BIO due to strong management guidance for 2026 revenue growth, favorable pricing trends, and healthy order momentum, particularly in the European and US markets. The company's confidence in operational execution and new technology platforms, such as bispecific antibodies, further supports its optimistic outlook, leading UBS to increase its target price and maintain a Buy rating.
HSBC
HSBC Global Investment Research
Buy
maintain
$44
2026-06-08
Reason
HSBC
HSBC Global Investment Research
Price Target
$44
2026-06-08
maintain
Buy
Reason
HSBC Global Investment Research has raised its revenue forecasts for WUXI BIO for 2027 to 2028 by 8% to 17% due to the company's interim growth guidance exceeding expectations. The broker is optimistic about the company's growth outlook, supported by strong growth momentum in its manufacturing business and a significant increase in integrated projects. The target price has been increased from HKD44 to HKD45.8, and the Buy rating is maintained.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for 02269
